In this installment of the “How I treat …” series in Blood, the authors present a concise practical review of vaccination guidelines for HCT recipients. They present 20 frequently asked questions (FAQs) to illustrate how to apply vaccination guidelines developed by the American Society for Blood and Marrow Transplantation (ASBMT), the European Society for Blood and Marrow Transplantation (EBMT), and the Infectious Disease Society of America (IDSA). The FAQs explain when adjustments should be made for different post-transplant clinical scenarios based on patient age, underlying diagnosis, or amount of immunosuppressive therapy.
Review: HCT Vaccination Guidelines
Apr 2016